Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence [PDF]
Clinical Reviews in Allergy and Immunology, 2020 AbstractChronic spontaneous urticaria (CSU) is defined as the spontaneous development of itchy hives and/or angioedema due to known or unknown causes that last for at least 6 weeks. At any given time, CSU is believed to affect 0.5–1% of the global population.
, Martin Metz, Emek Kocaturk
exaly +6 more sources
Updosing of nonsedating anti-histamines in recalcitrant chronic urticaria
Indian Journal of Dermatology, 2016 Chronic urticaria (CU) is a persistent, debiliating condition that causes severe impairment on the quality of life (QoL) of patient by interrupting work productivity.
Kiran Godse +4 more
doaj +3 more sources
Subcutaneous Allergen‐Specific Immunotherapy for Allergic Rhinitis: Divergent IgA Responses in Nasal Mucosa and Blood With Validation of B Cell Class‐Switching in Lymph Nodes and Blood [PDF]
Clinical and Translational AllergyBackground Subcutaneous immunotherapy (SCIT) has been a cornerstone treatment for allergic rhinitis (AR) for over 50 years, consistently demonstrating symptom reduction and modulation of immune responses.
Maryam Jafari +9 more
doaj +2 more sources
Clinical Dermatology Review, 2022 Background: Second-generation antihistamines (SGAHs) are first-line drugs in management of chronic spontaneous urticaria (CSU). However, almost 50% of the patients do not respond to standard dose of SGAH.
Bela Shah +6 more
doaj +2 more sources
Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy [PDF]
Journal of Allergy and Clinical Immunology: Global, 2023 Background: Oral immunotherapy containing peanut (Arachis hypogaea) allergen powder-dnfp (PTAH) (Palforzia [Aimmune Therapeutics, Brisbane, Calif]) for 9 to 12 months resulted in higher tolerated amounts of peanut protein in PTAH-treated individuals aged
J. Andrew Bird, MD +6 more
doaj +2 more sources
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
Therapeutics and Clinical Risk Management, 2016 Maria T Staevska Clinical Center of Allergology, Medical University, Sofia, Bulgaria As a group of allergists who treat both allergic rhinitis and urticaria patients on a daily basis, and involved in clinical research, we read with particular ...
Staevska MT
doaj +6 more sources
Respiratory Medicine Case Reports, 2022 Status asthmaticus is a life-threatening condition with a high mortality rate of up to 10.3% [1].Milger et al. recently described a rapid clinical improvement and a reduction in serum IgE levels in a patient with status asthmaticus who received salvage ...
Hortense Slevogt, Martin Brauer
doaj +3 more sources
Allergologia Et Immunopathologia, 2006 Due to optimal safety of sublingual immunotherapy (SLIT), it was suggested that a slow up-dosing phase maybe not necessary, and therefore the treatment will be more patient-friendly, avoiding dosing mistakes.Twenty adult patients suffering allergic rhinitis due to Parietaria, were enrolled.
Giorgio Walter Canonica +2 more
exaly +4 more sources
Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria [PDF]
World Allergy Organization Journal, 2014 Urticaria and angioedema lasting more than 6 weeks have been designated as chronic urticaria (CU). It encompasses two major subtypes: chronic spontaneous urticaria (CSU) (previously known as chronic idiopathic urticaria) (CIU) and chronic inducible urticaria.
Ignacio Javier Ansotegui Zubeldia +2 more
exaly +3 more sources
Clinico-Epidemiologic Profile and Response to Levocetirizine in Chronic Spontaneous Urticaria: A Retrospective Cohort Study from a Tertiary Care Center in North India [PDF]
Indian Dermatology Online JournalBackground: Comprehensive long-term follow-up data regarding chronic spontaneous urticaria (CSU) among general populations, especially from the Indian subcontinent is scanty.
Raihan Ashraf +4 more
doaj +2 more sources